The European baseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on Contact Allergies (ESSCA)

Wolfgang Uter, C. Rämsch, Werner Aberer, Fabio Ayala, Anna Balato, Aistė Beliauskienė, Anna Belloni Fortina, Andreas J. Bircher, Jochen Brasch, M.M.U. Chowdhury,

Contact Dermatitis · 2009 · 181 citations · 16 references

DOIFull text

Open access

Concepts

TL;DR

Patch‑test surveillance is a valuable tool for detecting contact allergy. The study aims to provide an up‑to‑date overview of contact‑allergy prevalence to key sensitizers across Europe. Data from 19,793 patients patch‑tested in 2005/2006 across 31 centers in 10 countries were descriptively analysed and aggregated into four European regions. Nickel sulfate was the most common allergen (19.7–24.4% across regions), most other allergens showed little regional variation, but some (e.g., dichromate, MCI/MI) varied, suggesting exposure differences and highlighting areas for further investigation.

Abstract

Background: Continual surveillance based on patch test results has proved useful for the identification of contact allergy. Objectives: To provide a current view on the spectrum of contact allergy to important sensitizers across Europe. Patients/Methods: Clinical and patch test data of 19 793 patients patch tested in 2005/2006 in the 31 participating departments from 10 European countries (the European Surveillance System on Contact Allergies' (ESSCA) www.essca‐dc.org ) were descriptively analysed, aggregated to four European regions. Results: Nickel sulfate remains the most common allergen with standardized prevalences ranging from 19.7% (central Europe) to 24.4% (southern Europe). While a number of allergens shows limited variation across the four regions, such as Myroxylon pereirae (5.3–6.8%), cobalt chloride (6.2–8.8%) or thiuram mix (1.7–2.4%), the differences observed with other allergens may hint on underlying differences in exposures, for example: dichromate 2.4% in the UK (west) versus 4.5–5.9% in the remaining EU regions, methylchloroisothiazolinone/methylisothiazolinone 4.1% in the South versus 2.1–2.7% in the remaining regions. Conclusions: Notwithstanding residual methodological variation (affecting at least some ‘difficult’ allergens) tackled by ongoing efforts for standardization, a comparative analysis as presented provides (i) a broad overview on contact allergy frequencies and (ii) interesting starting points for further, in‐depth investigation.

References

16